Cell Sheet Engineering from Japan to the World
CellSeed is committed to delivering medical treatments based on cell sheet engineering pioneered in Japan to patients worldwide in as quick a timeframe as possible.
CellSeed's Products and Services
CellSeed is taking on the challenge of "commercializing regenerative medicine" using cell sheets, including cell culture plates and other cell culture equipment, as well as contracted development and manufacturing services for cell sheets.
For Patients and Families
We are pleased to inform you about the regenerative medicine field that CellSeed is working on.
IR
We will inform you of statutory disclosures, a list of timely disclosures, financial information, etc.
Company Information
Greetings, company profile, Succeed's management philosophy, and introduction of the management team.
Notice
- IR Summary of Non-Consolidated Financial Results for the Three Months Ended March 31, 2026 (J-GAAP)
- Others Bridge Report the fiscal year 2025
- IR Granted Cartilage Regeneration Sheet Patent in Japan
- Event Product Display at American Association for Cancer Research® (AACR) Annual Meeting 2026
- IR Fiscal 2025 Earnings Results Presentation